Biktarvy, formally known as bictegravir sulfate, is a effective single-tablet therapy for treating HIV infection. This formula unites three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to multiply within the body, remarkably reducing the viral quantity. For many